Omada Health (OMDA) CAO sells 2,083 shares in 10b5-1 plan trade
Rhea-AI Filing Summary
Omada Health’s Chief Accounting Officer Craig Gracey reported an amended insider transaction showing a same-day option exercise and share sale. Gracey exercised 2,083 shares of Common Stock through a stock option with a $6.57 exercise price, then sold 2,083 shares in an open-market transaction at a weighted average price of $19.0118 per share.
The amendment corrects a prior Form 4 that reported the sale but inadvertently omitted the exercise, which had understated shares beneficially owned after the trade. Following the correction, Gracey directly holds 15,441 shares of Common Stock and 39,584 stock options that are exercisable at $6.57 and expire on October 23, 2034. The sale was executed under a Rule 10b5-1 trading plan adopted on March 13, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 2,083 | $0.00 | -- |
| Exercise | Common Stock | 2,083 | $6.57 | $14K |
| Sale | Common Stock | 2,083 | $19.0118 | $40K |
Footnotes (1)
- This Form 4/A restates in its entirety the original Form 4 filed on 6/26/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. This transaction was executed in multiple trades at prices ranging from $19.00 to $19.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. 25% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.